STOCK TITAN

Planned insider 144 sale highlights SOPH (NASDAQ: SOPH) share disposals

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An insider of the issuer of SOPH common stock has filed a Rule 144 notice to sell 7,485 shares of common stock through Morgan Stanley Smith Barney LLC, with an indicated aggregate market value of $40,793.25. The filing states that 67,847,058 shares of common stock were outstanding and lists an approximate sale date of January 20, 2026 on the NASDAQ exchange.

The securities to be sold include 2,999 shares acquired on January 20, 2026 via exercise of stock options for cash, and 4,486 shares acquired on January 18, 2026 as restricted stock units. The notice also details a series of prior Rule 10b5-1 plan sales for Jurgi Camblong over the past three months, with multiple transactions of common stock on various dates from October 2025 through January 2026, each showing the number of shares sold and related gross proceeds.

Positive

  • None.

Negative

  • None.

Insights

Form 144 shows ongoing, pre-planned insider stock sales under Rule 10b5-1.

The filing indicates that an insider of the issuer of SOPH common stock intends to sell 7,485 shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $40,793.25. These shares stem from recent equity compensation: stock options exercised for 2,999 shares and 4,486 restricted stock units that became deliverable in January 2026. The sale is to occur on NASDAQ around January 20, 2026.

The document also lists prior sales under a Rule 10b5-1 trading plan for Jurgi Camblong, covering many transactions between October 30, 2025 and January 16, 2026, each with specified share amounts and gross proceeds. Because these are plan-based trades, they are framed as pre-arranged rather than discretionary timing decisions. The insider further represents that they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many SOPH shares are covered by this Form 144 notice?

The Form 144 covers the intended sale of 7,485 shares of SOPH common stock, with an indicated aggregate market value of $40,793.25, to be sold through Morgan Stanley Smith Barney LLC on NASDAQ.

How many SOPH shares are outstanding according to this Form 144?

The notice states that there were 67,847,058 shares of SOPH common stock outstanding at the time referenced in the filing.

What is the source of the SOPH shares being sold under this Form 144?

The shares to be sold consist of 2,999 shares acquired on January 20, 2026 through the exercise of stock options for cash, and 4,486 shares acquired on January 18, 2026 as restricted stock units from the issuer.

When is the planned sale date and on which exchange will SOPH shares be sold?

The filing lists an approximate sale date of January 20, 2026 and identifies NASDAQ as the securities exchange where the SOPH common shares are expected to be sold.

What prior SOPH stock sales are disclosed for the past three months?

The notice discloses multiple prior sales of SOPH common stock under a Rule 10b5-1 plan for Jurgi Camblong from October 30, 2025 through January 16, 2026. Each entry lists the date, number of shares sold, and gross proceeds, including larger transactions such as 95,488 shares sold on January 9, 2026 and 24,641 shares sold on October 30, 2025.

What representation does the insider make regarding material information about SOPH?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, consistent with the Rule 10b5-1 acknowledgment language in the form.

Sophia Genetics Sa

NASDAQ:SOPH

SOPH Rankings

SOPH Latest News

SOPH Latest SEC Filings

SOPH Stock Data

354.16M
63.48M
6.46%
48.2%
0.06%
Health Information Services
Healthcare
Link
Switzerland
Rolle